STAT+: Is the White House’s deal with pharma on GLP-1 drugs a game changer?
President Trump last week hailed his deal with pharma companies to cut the price of blockbuster weight loss drugs as a major win for his administration and for increasing drug affordability. The question is how big of a difference the agreement will make for patients. The deal is expected to significantly expand access to GLP-1 […]
The Impact of GLP-1 Receptor Agonists on Clinical Outcomes and Healthcare Utilization in Hidradenitis Suppurativa Patients: A Retrospective Cohort Study Using TriNetX
Post Content
First it was Ozempic. Now the peptide gold rush is here — and it’s dangerous
Ozempic changed everything: Millions of Americans who have discovered the transformative power of one peptide are chasing their next fix
Gordon Ramsay calls Ozempic restaurant menus ‘absolute bulls—‘ in profanity-filled rant
Gordon Ramsay didn’t hold back when speaking out on whether he would alter his restaurants’ menus to cater to diners who are taking popular weight loss drugs including Ozempic and Mounjaro. During a recent interview with The Sunday Times, the 59-year-old celebrity chef was asked whether he would create special, smaller-portion menus for patrons using […]
Biomolecules, Vol. 15, Pages 1574: Current and Emerging Roles of GLP1 Receptor Agonists Across the Spectrum of Left Ventricular Ejection Fraction in Heart Failure
Biomolecules, Vol. 15, Pages 1574: Current and Emerging Roles of GLP1 Receptor Agonists Across the Spectrum of Left Ventricular Ejection Fraction in Heart Failure Biomolecules doi: 10.3390/biom15111574 Authors: Simone Pasquale Crispino Annunziata Nusca Aurora Ferro Riccardo Cricco Martina Ciancio Andrea Segreti Ilaria Cavallari Mario Sabatino Luciano Potena Gian Paolo Ussia Francesco Grigioni Glucagon-like peptide-1 receptor […]
Genes, Vol. 16, Pages 1352: GLP-1 Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways
Genes, Vol. 16, Pages 1352: GLP-1 Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways Genes doi: 10.3390/genes16111352 Authors: Daniela Lucente Stefania Bellino Anna La Salvia Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), initially developed to treat type 2 diabetes mellitus, are now being investigated as agents in oncology. Recent preclinical […]
Novo Nordisk’s Wegovy (semaglutide 2.4 mg) Was Associated with Liver Health-Related Benefits Not Solely Based on Weight Loss in Adult Patients with MASH with Liver Scarring
Plainsboro, NJ, US and Bagsværd, Denmark, 10 November 2025 – Novo Nordisk today presented data at the 76th annual American Association for the Study of Liver Diseases (AASLD) meeting, The Liver Meeting® 2025, in Washington, D.C…
Why this leading fundie is tipping ResMed shares for near-term gains
ResMed Inc (ASX: RMD) shares are marching higher today. Shares in the S&P/ASX 200 Index (ASX: XJO) sleep disorder treatment company closed on Friday trading for $38.32. In morning trade on Monday, shares are swapping hands for $38.58 each, up 0.7%. For some context, the ASX 200 is up 0.3% at this same time. Taking a […]
Scientists Say They’ve Figured Out a Way to Reprogram the Pancreas to Produce GLP-1s Without Ozempic – Futurism
Scientists Say They’ve Figured Out a Way to Reprogram the Pancreas to Produce GLP-1s Without Ozempic Futurism The race is on to turn your body into a GLP-1 factory CNN Ozempic killer? New drug reprograms metabolism for lasting weight loss New Atlas Biotech Startups Develop Gene Therapies for Obesity Using GLP-1 Букви
Weight-loss drugs are booming in these US states — with nearly 25% on GLP-1 meds in one obesity hot spot
With new agreements from President Donald Trump promising lower prices on popular weight-loss drugs, the use of GLP-1 medications such as Ozempic and Mounjaro could soon surge even higher.